nodes	percent_of_prediction	percent_of_DWPC	metapath
Escitalopram—CYP2C19—Efavirenz—acquired immunodeficiency syndrome	0.0398	0.061	CbGbCtD
Escitalopram—CYP2C19—Lopinavir—acquired immunodeficiency syndrome	0.0375	0.0574	CbGbCtD
Escitalopram—CYP2C19—Amprenavir—acquired immunodeficiency syndrome	0.0339	0.0519	CbGbCtD
Escitalopram—CYP2C19—Delavirdine—acquired immunodeficiency syndrome	0.0339	0.0519	CbGbCtD
Escitalopram—CYP2D6—Efavirenz—acquired immunodeficiency syndrome	0.0303	0.0464	CbGbCtD
Escitalopram—CYP2C19—Indinavir—acquired immunodeficiency syndrome	0.0292	0.0448	CbGbCtD
Escitalopram—CYP2D6—Nevirapine—acquired immunodeficiency syndrome	0.0285	0.0436	CbGbCtD
Escitalopram—CYP2D6—Lopinavir—acquired immunodeficiency syndrome	0.0285	0.0436	CbGbCtD
Escitalopram—CYP2C19—Nelfinavir—acquired immunodeficiency syndrome	0.0284	0.0435	CbGbCtD
Escitalopram—CYP2D6—Amprenavir—acquired immunodeficiency syndrome	0.0258	0.0394	CbGbCtD
Escitalopram—CYP2D6—Delavirdine—acquired immunodeficiency syndrome	0.0258	0.0394	CbGbCtD
Escitalopram—CYP2C19—Saquinavir—acquired immunodeficiency syndrome	0.0257	0.0393	CbGbCtD
Escitalopram—CYP2C19—Ritonavir—acquired immunodeficiency syndrome	0.0257	0.0393	CbGbCtD
Escitalopram—CYP2C19—Zidovudine—acquired immunodeficiency syndrome	0.0246	0.0377	CbGbCtD
Escitalopram—CYP2D6—Indinavir—acquired immunodeficiency syndrome	0.0222	0.0341	CbGbCtD
Escitalopram—CYP2D6—Nelfinavir—acquired immunodeficiency syndrome	0.0216	0.0331	CbGbCtD
Escitalopram—CYP2D6—Ritonavir—acquired immunodeficiency syndrome	0.0195	0.0299	CbGbCtD
Escitalopram—CYP2D6—Saquinavir—acquired immunodeficiency syndrome	0.0195	0.0299	CbGbCtD
Escitalopram—CYP3A4—Efavirenz—acquired immunodeficiency syndrome	0.0193	0.0295	CbGbCtD
Escitalopram—CYP3A4—Lopinavir—acquired immunodeficiency syndrome	0.0181	0.0277	CbGbCtD
Escitalopram—CYP3A4—Nevirapine—acquired immunodeficiency syndrome	0.0181	0.0277	CbGbCtD
Escitalopram—CYP3A4—Amprenavir—acquired immunodeficiency syndrome	0.0164	0.0251	CbGbCtD
Escitalopram—CYP3A4—Delavirdine—acquired immunodeficiency syndrome	0.0164	0.0251	CbGbCtD
Escitalopram—CYP3A4—Indinavir—acquired immunodeficiency syndrome	0.0141	0.0217	CbGbCtD
Escitalopram—CYP3A4—Nelfinavir—acquired immunodeficiency syndrome	0.0137	0.021	CbGbCtD
Escitalopram—CYP3A4—Saquinavir—acquired immunodeficiency syndrome	0.0124	0.019	CbGbCtD
Escitalopram—CYP3A4—Ritonavir—acquired immunodeficiency syndrome	0.0124	0.019	CbGbCtD
Escitalopram—CYP3A4—Zidovudine—acquired immunodeficiency syndrome	0.0119	0.0182	CbGbCtD
Escitalopram—SLC6A3—nerve—acquired immunodeficiency syndrome	0.00264	0.0814	CbGeAlD
Escitalopram—SLC6A2—nerve—acquired immunodeficiency syndrome	0.00213	0.0657	CbGeAlD
Escitalopram—SLC6A4—blood plasma—acquired immunodeficiency syndrome	0.00183	0.0564	CbGeAlD
Escitalopram—CYP2C19—blood plasma—acquired immunodeficiency syndrome	0.00152	0.0468	CbGeAlD
Escitalopram—CYP3A4—blood plasma—acquired immunodeficiency syndrome	0.000896	0.0276	CbGeAlD
Escitalopram—CYP2D6—blood plasma—acquired immunodeficiency syndrome	0.000882	0.0272	CbGeAlD
Escitalopram—SLC6A3—spinal cord—acquired immunodeficiency syndrome	0.000705	0.0217	CbGeAlD
Escitalopram—SLC6A4—digestive system—acquired immunodeficiency syndrome	0.000704	0.0217	CbGeAlD
Escitalopram—HTR2C—spinal cord—acquired immunodeficiency syndrome	0.000681	0.021	CbGeAlD
Escitalopram—SLC6A4—blood—acquired immunodeficiency syndrome	0.00067	0.0207	CbGeAlD
Escitalopram—SLC6A4—spinal cord—acquired immunodeficiency syndrome	0.000646	0.0199	CbGeAlD
Escitalopram—SLC6A3—lung—acquired immunodeficiency syndrome	0.000641	0.0198	CbGeAlD
Escitalopram—SLC6A3—nervous system—acquired immunodeficiency syndrome	0.000594	0.0183	CbGeAlD
Escitalopram—SLC6A4—lung—acquired immunodeficiency syndrome	0.000588	0.0181	CbGeAlD
Escitalopram—CHRM1—lung—acquired immunodeficiency syndrome	0.000585	0.0181	CbGeAlD
Escitalopram—CYP2C19—digestive system—acquired immunodeficiency syndrome	0.000583	0.018	CbGeAlD
Escitalopram—ADRA1A—lymphoid tissue—acquired immunodeficiency syndrome	0.000583	0.018	CbGeAlD
Escitalopram—HTR2C—nervous system—acquired immunodeficiency syndrome	0.000574	0.0177	CbGeAlD
Escitalopram—SLC6A3—central nervous system—acquired immunodeficiency syndrome	0.000572	0.0176	CbGeAlD
Escitalopram—CYP2C19—blood—acquired immunodeficiency syndrome	0.000555	0.0171	CbGeAlD
Escitalopram—HTR2C—central nervous system—acquired immunodeficiency syndrome	0.000553	0.017	CbGeAlD
Escitalopram—ADRA1A—blood—acquired immunodeficiency syndrome	0.000549	0.0169	CbGeAlD
Escitalopram—SLC6A4—nervous system—acquired immunodeficiency syndrome	0.000544	0.0168	CbGeAlD
Escitalopram—CHRM1—nervous system—acquired immunodeficiency syndrome	0.000542	0.0167	CbGeAlD
Escitalopram—SLC6A4—central nervous system—acquired immunodeficiency syndrome	0.000524	0.0162	CbGeAlD
Escitalopram—CHRM1—central nervous system—acquired immunodeficiency syndrome	0.000522	0.0161	CbGeAlD
Escitalopram—SLC6A2—lung—acquired immunodeficiency syndrome	0.000517	0.016	CbGeAlD
Escitalopram—CYP2C19—vagina—acquired immunodeficiency syndrome	0.000515	0.0159	CbGeAlD
Escitalopram—SLC6A2—nervous system—acquired immunodeficiency syndrome	0.000479	0.0148	CbGeAlD
Escitalopram—SLC6A2—central nervous system—acquired immunodeficiency syndrome	0.000461	0.0142	CbGeAlD
Escitalopram—SLC6A3—brain—acquired immunodeficiency syndrome	0.000454	0.014	CbGeAlD
Escitalopram—HRH1—digestive system—acquired immunodeficiency syndrome	0.000446	0.0137	CbGeAlD
Escitalopram—ADRA1A—nervous system—acquired immunodeficiency syndrome	0.000445	0.0137	CbGeAlD
Escitalopram—HTR2C—brain—acquired immunodeficiency syndrome	0.000439	0.0135	CbGeAlD
Escitalopram—ADRA1A—central nervous system—acquired immunodeficiency syndrome	0.000429	0.0132	CbGeAlD
Escitalopram—SLC6A4—brain—acquired immunodeficiency syndrome	0.000416	0.0128	CbGeAlD
Escitalopram—CHRM1—brain—acquired immunodeficiency syndrome	0.000414	0.0128	CbGeAlD
Escitalopram—HRH1—vagina—acquired immunodeficiency syndrome	0.000394	0.0121	CbGeAlD
Escitalopram—HRH1—lung—acquired immunodeficiency syndrome	0.000372	0.0115	CbGeAlD
Escitalopram—SLC6A2—brain—acquired immunodeficiency syndrome	0.000366	0.0113	CbGeAlD
Escitalopram—SLC6A2—lymph node—acquired immunodeficiency syndrome	0.000354	0.0109	CbGeAlD
Escitalopram—HRH1—nervous system—acquired immunodeficiency syndrome	0.000345	0.0106	CbGeAlD
Escitalopram—CYP3A4—digestive system—acquired immunodeficiency syndrome	0.000345	0.0106	CbGeAlD
Escitalopram—ADRA1A—brain—acquired immunodeficiency syndrome	0.00034	0.0105	CbGeAlD
Escitalopram—CYP2D6—digestive system—acquired immunodeficiency syndrome	0.000339	0.0105	CbGeAlD
Escitalopram—HRH1—central nervous system—acquired immunodeficiency syndrome	0.000332	0.0102	CbGeAlD
Escitalopram—CYP3A4—blood—acquired immunodeficiency syndrome	0.000328	0.0101	CbGeAlD
Escitalopram—CYP2D6—blood—acquired immunodeficiency syndrome	0.000323	0.00997	CbGeAlD
Escitalopram—CYP3A4—nervous system—acquired immunodeficiency syndrome	0.000267	0.00822	CbGeAlD
Escitalopram—HRH1—brain—acquired immunodeficiency syndrome	0.000263	0.00813	CbGeAlD
Escitalopram—CYP2D6—nervous system—acquired immunodeficiency syndrome	0.000262	0.00809	CbGeAlD
Escitalopram—CYP3A4—central nervous system—acquired immunodeficiency syndrome	0.000257	0.00792	CbGeAlD
Escitalopram—HRH1—lymph node—acquired immunodeficiency syndrome	0.000255	0.00785	CbGeAlD
Escitalopram—CYP2D6—central nervous system—acquired immunodeficiency syndrome	0.000253	0.00779	CbGeAlD
Escitalopram—CYP2D6—brain—acquired immunodeficiency syndrome	0.0002	0.00618	CbGeAlD
Escitalopram—Unspecified disorder of skin and subcutaneous tissue—Ritonavir—acquired immunodeficiency syndrome	6.76e-05	0.000215	CcSEcCtD
Escitalopram—Gastrointestinal disorder—Indinavir—acquired immunodeficiency syndrome	6.74e-05	0.000214	CcSEcCtD
Escitalopram—Pruritus—Abacavir—acquired immunodeficiency syndrome	6.73e-05	0.000214	CcSEcCtD
Escitalopram—Fatigue—Indinavir—acquired immunodeficiency syndrome	6.73e-05	0.000214	CcSEcCtD
Escitalopram—Anorexia—Delavirdine—acquired immunodeficiency syndrome	6.72e-05	0.000214	CcSEcCtD
Escitalopram—Discomfort—Ritonavir—acquired immunodeficiency syndrome	6.72e-05	0.000214	CcSEcCtD
Escitalopram—Musculoskeletal discomfort—Efavirenz—acquired immunodeficiency syndrome	6.72e-05	0.000213	CcSEcCtD
Escitalopram—Cough—Saquinavir—acquired immunodeficiency syndrome	6.71e-05	0.000213	CcSEcCtD
Escitalopram—Angioedema—Lamivudine—acquired immunodeficiency syndrome	6.71e-05	0.000213	CcSEcCtD
Escitalopram—Constipation—Indinavir—acquired immunodeficiency syndrome	6.67e-05	0.000212	CcSEcCtD
Escitalopram—Pain—Indinavir—acquired immunodeficiency syndrome	6.67e-05	0.000212	CcSEcCtD
Escitalopram—Insomnia—Efavirenz—acquired immunodeficiency syndrome	6.67e-05	0.000212	CcSEcCtD
Escitalopram—Urticaria—Zidovudine—acquired immunodeficiency syndrome	6.67e-05	0.000212	CcSEcCtD
Escitalopram—Convulsion—Saquinavir—acquired immunodeficiency syndrome	6.67e-05	0.000212	CcSEcCtD
Escitalopram—Dry mouth—Ritonavir—acquired immunodeficiency syndrome	6.65e-05	0.000211	CcSEcCtD
Escitalopram—Hypertension—Saquinavir—acquired immunodeficiency syndrome	6.64e-05	0.000211	CcSEcCtD
Escitalopram—Abdominal pain—Zidovudine—acquired immunodeficiency syndrome	6.63e-05	0.000211	CcSEcCtD
Escitalopram—Body temperature increased—Zidovudine—acquired immunodeficiency syndrome	6.63e-05	0.000211	CcSEcCtD
Escitalopram—Diarrhoea—Nelfinavir—acquired immunodeficiency syndrome	6.62e-05	0.00021	CcSEcCtD
Escitalopram—Paraesthesia—Efavirenz—acquired immunodeficiency syndrome	6.62e-05	0.00021	CcSEcCtD
Escitalopram—Malaise—Lamivudine—acquired immunodeficiency syndrome	6.62e-05	0.00021	CcSEcCtD
Escitalopram—Diarrhoea—Stavudine—acquired immunodeficiency syndrome	6.6e-05	0.00021	CcSEcCtD
Escitalopram—Nausea—Didanosine—acquired immunodeficiency syndrome	6.6e-05	0.00021	CcSEcCtD
Escitalopram—Vertigo—Lamivudine—acquired immunodeficiency syndrome	6.59e-05	0.000209	CcSEcCtD
Escitalopram—Hypotension—Delavirdine—acquired immunodeficiency syndrome	6.59e-05	0.000209	CcSEcCtD
Escitalopram—Syncope—Lamivudine—acquired immunodeficiency syndrome	6.58e-05	0.000209	CcSEcCtD
Escitalopram—Confusional state—Ritonavir—acquired immunodeficiency syndrome	6.58e-05	0.000209	CcSEcCtD
Escitalopram—Dyspnoea—Efavirenz—acquired immunodeficiency syndrome	6.57e-05	0.000209	CcSEcCtD
Escitalopram—Leukopenia—Lamivudine—acquired immunodeficiency syndrome	6.57e-05	0.000209	CcSEcCtD
Escitalopram—Somnolence—Efavirenz—acquired immunodeficiency syndrome	6.55e-05	0.000208	CcSEcCtD
Escitalopram—Myalgia—Saquinavir—acquired immunodeficiency syndrome	6.55e-05	0.000208	CcSEcCtD
Escitalopram—Chest pain—Saquinavir—acquired immunodeficiency syndrome	6.55e-05	0.000208	CcSEcCtD
Escitalopram—Arthralgia—Saquinavir—acquired immunodeficiency syndrome	6.55e-05	0.000208	CcSEcCtD
Escitalopram—Anxiety—Saquinavir—acquired immunodeficiency syndrome	6.53e-05	0.000207	CcSEcCtD
Escitalopram—Oedema—Ritonavir—acquired immunodeficiency syndrome	6.52e-05	0.000207	CcSEcCtD
Escitalopram—Diarrhoea—Abacavir—acquired immunodeficiency syndrome	6.51e-05	0.000207	CcSEcCtD
Escitalopram—Unspecified disorder of skin and subcutaneous tissue—Saquinavir—acquired immunodeficiency syndrome	6.5e-05	0.000207	CcSEcCtD
Escitalopram—Dyspepsia—Efavirenz—acquired immunodeficiency syndrome	6.49e-05	0.000206	CcSEcCtD
Escitalopram—Discomfort—Saquinavir—acquired immunodeficiency syndrome	6.47e-05	0.000206	CcSEcCtD
Escitalopram—Loss of consciousness—Lamivudine—acquired immunodeficiency syndrome	6.45e-05	0.000205	CcSEcCtD
Escitalopram—Feeling abnormal—Indinavir—acquired immunodeficiency syndrome	6.43e-05	0.000204	CcSEcCtD
Escitalopram—Musculoskeletal discomfort—Delavirdine—acquired immunodeficiency syndrome	6.43e-05	0.000204	CcSEcCtD
Escitalopram—Shock—Ritonavir—acquired immunodeficiency syndrome	6.42e-05	0.000204	CcSEcCtD
Escitalopram—Decreased appetite—Efavirenz—acquired immunodeficiency syndrome	6.41e-05	0.000204	CcSEcCtD
Escitalopram—Dry mouth—Saquinavir—acquired immunodeficiency syndrome	6.41e-05	0.000203	CcSEcCtD
Escitalopram—Cough—Lamivudine—acquired immunodeficiency syndrome	6.4e-05	0.000203	CcSEcCtD
Escitalopram—Dizziness—Nelfinavir—acquired immunodeficiency syndrome	6.4e-05	0.000203	CcSEcCtD
Escitalopram—Nervous system disorder—Ritonavir—acquired immunodeficiency syndrome	6.4e-05	0.000203	CcSEcCtD
Escitalopram—Thrombocytopenia—Ritonavir—acquired immunodeficiency syndrome	6.39e-05	0.000203	CcSEcCtD
Escitalopram—Dizziness—Stavudine—acquired immunodeficiency syndrome	6.38e-05	0.000203	CcSEcCtD
Escitalopram—Gastrointestinal pain—Indinavir—acquired immunodeficiency syndrome	6.38e-05	0.000203	CcSEcCtD
Escitalopram—Insomnia—Delavirdine—acquired immunodeficiency syndrome	6.38e-05	0.000203	CcSEcCtD
Escitalopram—Tachycardia—Ritonavir—acquired immunodeficiency syndrome	6.37e-05	0.000202	CcSEcCtD
Escitalopram—Gastrointestinal disorder—Efavirenz—acquired immunodeficiency syndrome	6.36e-05	0.000202	CcSEcCtD
Escitalopram—Convulsion—Lamivudine—acquired immunodeficiency syndrome	6.36e-05	0.000202	CcSEcCtD
Escitalopram—Vomiting—Nevirapine—acquired immunodeficiency syndrome	6.36e-05	0.000202	CcSEcCtD
Escitalopram—Fatigue—Efavirenz—acquired immunodeficiency syndrome	6.36e-05	0.000202	CcSEcCtD
Escitalopram—Skin disorder—Ritonavir—acquired immunodeficiency syndrome	6.34e-05	0.000201	CcSEcCtD
Escitalopram—Paraesthesia—Delavirdine—acquired immunodeficiency syndrome	6.33e-05	0.000201	CcSEcCtD
Escitalopram—Confusional state—Saquinavir—acquired immunodeficiency syndrome	6.33e-05	0.000201	CcSEcCtD
Escitalopram—Hyperhidrosis—Ritonavir—acquired immunodeficiency syndrome	6.31e-05	0.0002	CcSEcCtD
Escitalopram—Pain—Efavirenz—acquired immunodeficiency syndrome	6.3e-05	0.0002	CcSEcCtD
Escitalopram—Constipation—Efavirenz—acquired immunodeficiency syndrome	6.3e-05	0.0002	CcSEcCtD
Escitalopram—Rash—Nevirapine—acquired immunodeficiency syndrome	6.3e-05	0.0002	CcSEcCtD
Escitalopram—Dermatitis—Nevirapine—acquired immunodeficiency syndrome	6.3e-05	0.0002	CcSEcCtD
Escitalopram—Dyspnoea—Delavirdine—acquired immunodeficiency syndrome	6.29e-05	0.0002	CcSEcCtD
Escitalopram—Dizziness—Abacavir—acquired immunodeficiency syndrome	6.29e-05	0.0002	CcSEcCtD
Escitalopram—Oedema—Saquinavir—acquired immunodeficiency syndrome	6.28e-05	0.000199	CcSEcCtD
Escitalopram—Somnolence—Delavirdine—acquired immunodeficiency syndrome	6.27e-05	0.000199	CcSEcCtD
Escitalopram—Headache—Nevirapine—acquired immunodeficiency syndrome	6.26e-05	0.000199	CcSEcCtD
Escitalopram—Arthralgia—Lamivudine—acquired immunodeficiency syndrome	6.25e-05	0.000198	CcSEcCtD
Escitalopram—Chest pain—Lamivudine—acquired immunodeficiency syndrome	6.25e-05	0.000198	CcSEcCtD
Escitalopram—Myalgia—Lamivudine—acquired immunodeficiency syndrome	6.25e-05	0.000198	CcSEcCtD
Escitalopram—Infection—Saquinavir—acquired immunodeficiency syndrome	6.24e-05	0.000198	CcSEcCtD
Escitalopram—Anxiety—Lamivudine—acquired immunodeficiency syndrome	6.23e-05	0.000198	CcSEcCtD
Escitalopram—Anorexia—Ritonavir—acquired immunodeficiency syndrome	6.22e-05	0.000198	CcSEcCtD
Escitalopram—Dyspepsia—Delavirdine—acquired immunodeficiency syndrome	6.21e-05	0.000197	CcSEcCtD
Escitalopram—Unspecified disorder of skin and subcutaneous tissue—Lamivudine—acquired immunodeficiency syndrome	6.2e-05	0.000197	CcSEcCtD
Escitalopram—Urticaria—Indinavir—acquired immunodeficiency syndrome	6.2e-05	0.000197	CcSEcCtD
Escitalopram—Shock—Saquinavir—acquired immunodeficiency syndrome	6.18e-05	0.000196	CcSEcCtD
Escitalopram—Discomfort—Lamivudine—acquired immunodeficiency syndrome	6.17e-05	0.000196	CcSEcCtD
Escitalopram—Body temperature increased—Indinavir—acquired immunodeficiency syndrome	6.17e-05	0.000196	CcSEcCtD
Escitalopram—Abdominal pain—Indinavir—acquired immunodeficiency syndrome	6.17e-05	0.000196	CcSEcCtD
Escitalopram—Nervous system disorder—Saquinavir—acquired immunodeficiency syndrome	6.16e-05	0.000196	CcSEcCtD
Escitalopram—Vomiting—Nelfinavir—acquired immunodeficiency syndrome	6.16e-05	0.000196	CcSEcCtD
Escitalopram—Thrombocytopenia—Saquinavir—acquired immunodeficiency syndrome	6.15e-05	0.000195	CcSEcCtD
Escitalopram—Vomiting—Stavudine—acquired immunodeficiency syndrome	6.14e-05	0.000195	CcSEcCtD
Escitalopram—Decreased appetite—Delavirdine—acquired immunodeficiency syndrome	6.13e-05	0.000195	CcSEcCtD
Escitalopram—Dry mouth—Lamivudine—acquired immunodeficiency syndrome	6.11e-05	0.000194	CcSEcCtD
Escitalopram—Rash—Nelfinavir—acquired immunodeficiency syndrome	6.11e-05	0.000194	CcSEcCtD
Escitalopram—Dermatitis—Nelfinavir—acquired immunodeficiency syndrome	6.1e-05	0.000194	CcSEcCtD
Escitalopram—Skin disorder—Saquinavir—acquired immunodeficiency syndrome	6.1e-05	0.000194	CcSEcCtD
Escitalopram—Hypotension—Ritonavir—acquired immunodeficiency syndrome	6.1e-05	0.000194	CcSEcCtD
Escitalopram—Gastrointestinal disorder—Delavirdine—acquired immunodeficiency syndrome	6.09e-05	0.000193	CcSEcCtD
Escitalopram—Rash—Stavudine—acquired immunodeficiency syndrome	6.09e-05	0.000193	CcSEcCtD
Escitalopram—Fatigue—Delavirdine—acquired immunodeficiency syndrome	6.08e-05	0.000193	CcSEcCtD
Escitalopram—Dermatitis—Stavudine—acquired immunodeficiency syndrome	6.08e-05	0.000193	CcSEcCtD
Escitalopram—Feeling abnormal—Efavirenz—acquired immunodeficiency syndrome	6.08e-05	0.000193	CcSEcCtD
Escitalopram—Hyperhidrosis—Saquinavir—acquired immunodeficiency syndrome	6.07e-05	0.000193	CcSEcCtD
Escitalopram—Headache—Nelfinavir—acquired immunodeficiency syndrome	6.07e-05	0.000193	CcSEcCtD
Escitalopram—Headache—Stavudine—acquired immunodeficiency syndrome	6.05e-05	0.000192	CcSEcCtD
Escitalopram—Vomiting—Abacavir—acquired immunodeficiency syndrome	6.05e-05	0.000192	CcSEcCtD
Escitalopram—Confusional state—Lamivudine—acquired immunodeficiency syndrome	6.04e-05	0.000192	CcSEcCtD
Escitalopram—Pain—Delavirdine—acquired immunodeficiency syndrome	6.03e-05	0.000192	CcSEcCtD
Escitalopram—Constipation—Delavirdine—acquired immunodeficiency syndrome	6.03e-05	0.000192	CcSEcCtD
Escitalopram—Gastrointestinal pain—Efavirenz—acquired immunodeficiency syndrome	6.03e-05	0.000192	CcSEcCtD
Escitalopram—Asthenia—Zidovudine—acquired immunodeficiency syndrome	6.02e-05	0.000191	CcSEcCtD
Escitalopram—Rash—Abacavir—acquired immunodeficiency syndrome	6e-05	0.00019	CcSEcCtD
Escitalopram—Dermatitis—Abacavir—acquired immunodeficiency syndrome	5.99e-05	0.00019	CcSEcCtD
Escitalopram—Oedema—Lamivudine—acquired immunodeficiency syndrome	5.99e-05	0.00019	CcSEcCtD
Escitalopram—Anaphylactic shock—Lamivudine—acquired immunodeficiency syndrome	5.99e-05	0.00019	CcSEcCtD
Escitalopram—Anorexia—Saquinavir—acquired immunodeficiency syndrome	5.98e-05	0.00019	CcSEcCtD
Escitalopram—Headache—Abacavir—acquired immunodeficiency syndrome	5.96e-05	0.000189	CcSEcCtD
Escitalopram—Infection—Lamivudine—acquired immunodeficiency syndrome	5.95e-05	0.000189	CcSEcCtD
Escitalopram—Musculoskeletal discomfort—Ritonavir—acquired immunodeficiency syndrome	5.94e-05	0.000189	CcSEcCtD
Escitalopram—Nausea—Nevirapine—acquired immunodeficiency syndrome	5.94e-05	0.000189	CcSEcCtD
Escitalopram—Pruritus—Zidovudine—acquired immunodeficiency syndrome	5.94e-05	0.000189	CcSEcCtD
Escitalopram—Insomnia—Ritonavir—acquired immunodeficiency syndrome	5.9e-05	0.000187	CcSEcCtD
Escitalopram—Shock—Lamivudine—acquired immunodeficiency syndrome	5.89e-05	0.000187	CcSEcCtD
Escitalopram—Nervous system disorder—Lamivudine—acquired immunodeficiency syndrome	5.87e-05	0.000187	CcSEcCtD
Escitalopram—Hypotension—Saquinavir—acquired immunodeficiency syndrome	5.87e-05	0.000186	CcSEcCtD
Escitalopram—Thrombocytopenia—Lamivudine—acquired immunodeficiency syndrome	5.86e-05	0.000186	CcSEcCtD
Escitalopram—Paraesthesia—Ritonavir—acquired immunodeficiency syndrome	5.86e-05	0.000186	CcSEcCtD
Escitalopram—Urticaria—Efavirenz—acquired immunodeficiency syndrome	5.86e-05	0.000186	CcSEcCtD
Escitalopram—Abdominal pain—Efavirenz—acquired immunodeficiency syndrome	5.83e-05	0.000185	CcSEcCtD
Escitalopram—Body temperature increased—Efavirenz—acquired immunodeficiency syndrome	5.83e-05	0.000185	CcSEcCtD
Escitalopram—Skin disorder—Lamivudine—acquired immunodeficiency syndrome	5.82e-05	0.000185	CcSEcCtD
Escitalopram—Dyspnoea—Ritonavir—acquired immunodeficiency syndrome	5.82e-05	0.000185	CcSEcCtD
Escitalopram—Feeling abnormal—Delavirdine—acquired immunodeficiency syndrome	5.81e-05	0.000185	CcSEcCtD
Escitalopram—Somnolence—Ritonavir—acquired immunodeficiency syndrome	5.8e-05	0.000184	CcSEcCtD
Escitalopram—Hyperhidrosis—Lamivudine—acquired immunodeficiency syndrome	5.79e-05	0.000184	CcSEcCtD
Escitalopram—Gastrointestinal pain—Delavirdine—acquired immunodeficiency syndrome	5.77e-05	0.000183	CcSEcCtD
Escitalopram—Nausea—Nelfinavir—acquired immunodeficiency syndrome	5.75e-05	0.000183	CcSEcCtD
Escitalopram—Hypersensitivity—Indinavir—acquired immunodeficiency syndrome	5.75e-05	0.000183	CcSEcCtD
Escitalopram—Dyspepsia—Ritonavir—acquired immunodeficiency syndrome	5.74e-05	0.000182	CcSEcCtD
Escitalopram—Diarrhoea—Zidovudine—acquired immunodeficiency syndrome	5.74e-05	0.000182	CcSEcCtD
Escitalopram—Nausea—Stavudine—acquired immunodeficiency syndrome	5.73e-05	0.000182	CcSEcCtD
Escitalopram—Musculoskeletal discomfort—Saquinavir—acquired immunodeficiency syndrome	5.72e-05	0.000182	CcSEcCtD
Escitalopram—Anorexia—Lamivudine—acquired immunodeficiency syndrome	5.71e-05	0.000181	CcSEcCtD
Escitalopram—Insomnia—Saquinavir—acquired immunodeficiency syndrome	5.68e-05	0.00018	CcSEcCtD
Escitalopram—Decreased appetite—Ritonavir—acquired immunodeficiency syndrome	5.67e-05	0.00018	CcSEcCtD
Escitalopram—Nausea—Abacavir—acquired immunodeficiency syndrome	5.65e-05	0.000179	CcSEcCtD
Escitalopram—Paraesthesia—Saquinavir—acquired immunodeficiency syndrome	5.64e-05	0.000179	CcSEcCtD
Escitalopram—Gastrointestinal disorder—Ritonavir—acquired immunodeficiency syndrome	5.63e-05	0.000179	CcSEcCtD
Escitalopram—Fatigue—Ritonavir—acquired immunodeficiency syndrome	5.62e-05	0.000179	CcSEcCtD
Escitalopram—Urticaria—Delavirdine—acquired immunodeficiency syndrome	5.6e-05	0.000178	CcSEcCtD
Escitalopram—Asthenia—Indinavir—acquired immunodeficiency syndrome	5.6e-05	0.000178	CcSEcCtD
Escitalopram—Dyspnoea—Saquinavir—acquired immunodeficiency syndrome	5.6e-05	0.000178	CcSEcCtD
Escitalopram—Hypotension—Lamivudine—acquired immunodeficiency syndrome	5.6e-05	0.000178	CcSEcCtD
Escitalopram—Somnolence—Saquinavir—acquired immunodeficiency syndrome	5.58e-05	0.000177	CcSEcCtD
Escitalopram—Pain—Ritonavir—acquired immunodeficiency syndrome	5.58e-05	0.000177	CcSEcCtD
Escitalopram—Constipation—Ritonavir—acquired immunodeficiency syndrome	5.58e-05	0.000177	CcSEcCtD
Escitalopram—Body temperature increased—Delavirdine—acquired immunodeficiency syndrome	5.58e-05	0.000177	CcSEcCtD
Escitalopram—Abdominal pain—Delavirdine—acquired immunodeficiency syndrome	5.58e-05	0.000177	CcSEcCtD
Escitalopram—Dizziness—Zidovudine—acquired immunodeficiency syndrome	5.55e-05	0.000176	CcSEcCtD
Escitalopram—Dyspepsia—Saquinavir—acquired immunodeficiency syndrome	5.53e-05	0.000176	CcSEcCtD
Escitalopram—Pruritus—Indinavir—acquired immunodeficiency syndrome	5.52e-05	0.000175	CcSEcCtD
Escitalopram—Decreased appetite—Saquinavir—acquired immunodeficiency syndrome	5.46e-05	0.000173	CcSEcCtD
Escitalopram—Musculoskeletal discomfort—Lamivudine—acquired immunodeficiency syndrome	5.46e-05	0.000173	CcSEcCtD
Escitalopram—Hypersensitivity—Efavirenz—acquired immunodeficiency syndrome	5.43e-05	0.000173	CcSEcCtD
Escitalopram—Gastrointestinal disorder—Saquinavir—acquired immunodeficiency syndrome	5.42e-05	0.000172	CcSEcCtD
Escitalopram—Insomnia—Lamivudine—acquired immunodeficiency syndrome	5.42e-05	0.000172	CcSEcCtD
Escitalopram—Fatigue—Saquinavir—acquired immunodeficiency syndrome	5.41e-05	0.000172	CcSEcCtD
Escitalopram—Paraesthesia—Lamivudine—acquired immunodeficiency syndrome	5.38e-05	0.000171	CcSEcCtD
Escitalopram—Feeling abnormal—Ritonavir—acquired immunodeficiency syndrome	5.38e-05	0.000171	CcSEcCtD
Escitalopram—Pain—Saquinavir—acquired immunodeficiency syndrome	5.37e-05	0.000171	CcSEcCtD
Escitalopram—Constipation—Saquinavir—acquired immunodeficiency syndrome	5.37e-05	0.000171	CcSEcCtD
Escitalopram—Dyspnoea—Lamivudine—acquired immunodeficiency syndrome	5.34e-05	0.00017	CcSEcCtD
Escitalopram—Diarrhoea—Indinavir—acquired immunodeficiency syndrome	5.34e-05	0.00017	CcSEcCtD
Escitalopram—Vomiting—Zidovudine—acquired immunodeficiency syndrome	5.33e-05	0.000169	CcSEcCtD
Escitalopram—Gastrointestinal pain—Ritonavir—acquired immunodeficiency syndrome	5.33e-05	0.000169	CcSEcCtD
Escitalopram—Somnolence—Lamivudine—acquired immunodeficiency syndrome	5.32e-05	0.000169	CcSEcCtD
Escitalopram—Rash—Zidovudine—acquired immunodeficiency syndrome	5.29e-05	0.000168	CcSEcCtD
Escitalopram—Asthenia—Efavirenz—acquired immunodeficiency syndrome	5.29e-05	0.000168	CcSEcCtD
Escitalopram—Dermatitis—Zidovudine—acquired immunodeficiency syndrome	5.29e-05	0.000168	CcSEcCtD
Escitalopram—Dyspepsia—Lamivudine—acquired immunodeficiency syndrome	5.27e-05	0.000167	CcSEcCtD
Escitalopram—Headache—Zidovudine—acquired immunodeficiency syndrome	5.26e-05	0.000167	CcSEcCtD
Escitalopram—Pruritus—Efavirenz—acquired immunodeficiency syndrome	5.22e-05	0.000166	CcSEcCtD
Escitalopram—Decreased appetite—Lamivudine—acquired immunodeficiency syndrome	5.21e-05	0.000165	CcSEcCtD
Escitalopram—Hypersensitivity—Delavirdine—acquired immunodeficiency syndrome	5.2e-05	0.000165	CcSEcCtD
Escitalopram—Urticaria—Ritonavir—acquired immunodeficiency syndrome	5.18e-05	0.000165	CcSEcCtD
Escitalopram—Feeling abnormal—Saquinavir—acquired immunodeficiency syndrome	5.17e-05	0.000164	CcSEcCtD
Escitalopram—Gastrointestinal disorder—Lamivudine—acquired immunodeficiency syndrome	5.17e-05	0.000164	CcSEcCtD
Escitalopram—Fatigue—Lamivudine—acquired immunodeficiency syndrome	5.16e-05	0.000164	CcSEcCtD
Escitalopram—Dizziness—Indinavir—acquired immunodeficiency syndrome	5.16e-05	0.000164	CcSEcCtD
Escitalopram—Body temperature increased—Ritonavir—acquired immunodeficiency syndrome	5.16e-05	0.000164	CcSEcCtD
Escitalopram—Abdominal pain—Ritonavir—acquired immunodeficiency syndrome	5.16e-05	0.000164	CcSEcCtD
Escitalopram—Gastrointestinal pain—Saquinavir—acquired immunodeficiency syndrome	5.13e-05	0.000163	CcSEcCtD
Escitalopram—Constipation—Lamivudine—acquired immunodeficiency syndrome	5.12e-05	0.000163	CcSEcCtD
Escitalopram—Pain—Lamivudine—acquired immunodeficiency syndrome	5.12e-05	0.000163	CcSEcCtD
Escitalopram—Asthenia—Delavirdine—acquired immunodeficiency syndrome	5.06e-05	0.000161	CcSEcCtD
Escitalopram—Diarrhoea—Efavirenz—acquired immunodeficiency syndrome	5.04e-05	0.00016	CcSEcCtD
Escitalopram—Pruritus—Delavirdine—acquired immunodeficiency syndrome	4.99e-05	0.000159	CcSEcCtD
Escitalopram—Urticaria—Saquinavir—acquired immunodeficiency syndrome	4.99e-05	0.000158	CcSEcCtD
Escitalopram—Nausea—Zidovudine—acquired immunodeficiency syndrome	4.98e-05	0.000158	CcSEcCtD
Escitalopram—Abdominal pain—Saquinavir—acquired immunodeficiency syndrome	4.96e-05	0.000158	CcSEcCtD
Escitalopram—Body temperature increased—Saquinavir—acquired immunodeficiency syndrome	4.96e-05	0.000158	CcSEcCtD
Escitalopram—Vomiting—Indinavir—acquired immunodeficiency syndrome	4.96e-05	0.000158	CcSEcCtD
Escitalopram—Feeling abnormal—Lamivudine—acquired immunodeficiency syndrome	4.94e-05	0.000157	CcSEcCtD
Escitalopram—Rash—Indinavir—acquired immunodeficiency syndrome	4.92e-05	0.000156	CcSEcCtD
Escitalopram—Dermatitis—Indinavir—acquired immunodeficiency syndrome	4.92e-05	0.000156	CcSEcCtD
Escitalopram—Gastrointestinal pain—Lamivudine—acquired immunodeficiency syndrome	4.9e-05	0.000156	CcSEcCtD
Escitalopram—Headache—Indinavir—acquired immunodeficiency syndrome	4.89e-05	0.000155	CcSEcCtD
Escitalopram—Dizziness—Efavirenz—acquired immunodeficiency syndrome	4.88e-05	0.000155	CcSEcCtD
Escitalopram—Diarrhoea—Delavirdine—acquired immunodeficiency syndrome	4.83e-05	0.000153	CcSEcCtD
Escitalopram—Hypersensitivity—Ritonavir—acquired immunodeficiency syndrome	4.81e-05	0.000153	CcSEcCtD
Escitalopram—Urticaria—Lamivudine—acquired immunodeficiency syndrome	4.76e-05	0.000151	CcSEcCtD
Escitalopram—Abdominal pain—Lamivudine—acquired immunodeficiency syndrome	4.73e-05	0.00015	CcSEcCtD
Escitalopram—Body temperature increased—Lamivudine—acquired immunodeficiency syndrome	4.73e-05	0.00015	CcSEcCtD
Escitalopram—Vomiting—Efavirenz—acquired immunodeficiency syndrome	4.69e-05	0.000149	CcSEcCtD
Escitalopram—Asthenia—Ritonavir—acquired immunodeficiency syndrome	4.68e-05	0.000149	CcSEcCtD
Escitalopram—Dizziness—Delavirdine—acquired immunodeficiency syndrome	4.66e-05	0.000148	CcSEcCtD
Escitalopram—Rash—Efavirenz—acquired immunodeficiency syndrome	4.65e-05	0.000148	CcSEcCtD
Escitalopram—Dermatitis—Efavirenz—acquired immunodeficiency syndrome	4.64e-05	0.000148	CcSEcCtD
Escitalopram—Nausea—Indinavir—acquired immunodeficiency syndrome	4.63e-05	0.000147	CcSEcCtD
Escitalopram—Hypersensitivity—Saquinavir—acquired immunodeficiency syndrome	4.63e-05	0.000147	CcSEcCtD
Escitalopram—Headache—Efavirenz—acquired immunodeficiency syndrome	4.62e-05	0.000147	CcSEcCtD
Escitalopram—Pruritus—Ritonavir—acquired immunodeficiency syndrome	4.61e-05	0.000147	CcSEcCtD
Escitalopram—Asthenia—Saquinavir—acquired immunodeficiency syndrome	4.5e-05	0.000143	CcSEcCtD
Escitalopram—Vomiting—Delavirdine—acquired immunodeficiency syndrome	4.48e-05	0.000142	CcSEcCtD
Escitalopram—Diarrhoea—Ritonavir—acquired immunodeficiency syndrome	4.46e-05	0.000142	CcSEcCtD
Escitalopram—Rash—Delavirdine—acquired immunodeficiency syndrome	4.45e-05	0.000141	CcSEcCtD
Escitalopram—Dermatitis—Delavirdine—acquired immunodeficiency syndrome	4.44e-05	0.000141	CcSEcCtD
Escitalopram—Pruritus—Saquinavir—acquired immunodeficiency syndrome	4.44e-05	0.000141	CcSEcCtD
Escitalopram—Headache—Delavirdine—acquired immunodeficiency syndrome	4.42e-05	0.00014	CcSEcCtD
Escitalopram—Hypersensitivity—Lamivudine—acquired immunodeficiency syndrome	4.41e-05	0.00014	CcSEcCtD
Escitalopram—Nausea—Efavirenz—acquired immunodeficiency syndrome	4.38e-05	0.000139	CcSEcCtD
Escitalopram—Dizziness—Ritonavir—acquired immunodeficiency syndrome	4.31e-05	0.000137	CcSEcCtD
Escitalopram—Asthenia—Lamivudine—acquired immunodeficiency syndrome	4.3e-05	0.000137	CcSEcCtD
Escitalopram—Diarrhoea—Saquinavir—acquired immunodeficiency syndrome	4.3e-05	0.000136	CcSEcCtD
Escitalopram—Pruritus—Lamivudine—acquired immunodeficiency syndrome	4.24e-05	0.000135	CcSEcCtD
Escitalopram—Nausea—Delavirdine—acquired immunodeficiency syndrome	4.19e-05	0.000133	CcSEcCtD
Escitalopram—Dizziness—Saquinavir—acquired immunodeficiency syndrome	4.15e-05	0.000132	CcSEcCtD
Escitalopram—Vomiting—Ritonavir—acquired immunodeficiency syndrome	4.15e-05	0.000132	CcSEcCtD
Escitalopram—Rash—Ritonavir—acquired immunodeficiency syndrome	4.11e-05	0.000131	CcSEcCtD
Escitalopram—Dermatitis—Ritonavir—acquired immunodeficiency syndrome	4.11e-05	0.000131	CcSEcCtD
Escitalopram—Diarrhoea—Lamivudine—acquired immunodeficiency syndrome	4.1e-05	0.00013	CcSEcCtD
Escitalopram—Headache—Ritonavir—acquired immunodeficiency syndrome	4.09e-05	0.00013	CcSEcCtD
Escitalopram—Vomiting—Saquinavir—acquired immunodeficiency syndrome	3.99e-05	0.000127	CcSEcCtD
Escitalopram—Dizziness—Lamivudine—acquired immunodeficiency syndrome	3.96e-05	0.000126	CcSEcCtD
Escitalopram—Rash—Saquinavir—acquired immunodeficiency syndrome	3.96e-05	0.000126	CcSEcCtD
Escitalopram—Dermatitis—Saquinavir—acquired immunodeficiency syndrome	3.95e-05	0.000126	CcSEcCtD
Escitalopram—Headache—Saquinavir—acquired immunodeficiency syndrome	3.93e-05	0.000125	CcSEcCtD
Escitalopram—Nausea—Ritonavir—acquired immunodeficiency syndrome	3.87e-05	0.000123	CcSEcCtD
Escitalopram—Vomiting—Lamivudine—acquired immunodeficiency syndrome	3.81e-05	0.000121	CcSEcCtD
Escitalopram—Rash—Lamivudine—acquired immunodeficiency syndrome	3.78e-05	0.00012	CcSEcCtD
Escitalopram—Dermatitis—Lamivudine—acquired immunodeficiency syndrome	3.77e-05	0.00012	CcSEcCtD
Escitalopram—Headache—Lamivudine—acquired immunodeficiency syndrome	3.75e-05	0.000119	CcSEcCtD
Escitalopram—Nausea—Saquinavir—acquired immunodeficiency syndrome	3.73e-05	0.000118	CcSEcCtD
Escitalopram—Nausea—Lamivudine—acquired immunodeficiency syndrome	3.56e-05	0.000113	CcSEcCtD
